Marc-André d'Entremont, Dennis Ko, Andrew T Yan, Shaun G Goodman, Jiayi Ni, Paul Poirier, Jean-Claude Tardif, Jean C Grégoire, Étienne L Couture, Michel Nguyen, George Thanassoulis, Abhinav Sharma, Thao Huynh
INTRODUCTION: It remains unclear if racial and ethnic disparities for atherosclerotic cardiovascular disease (ASCVD) persists within universal healthcare systems. We aimed to explore long-term ASCVD outcomes within a single-payer healthcare system with extensive drug coverage in Quebec, Canada. METHODS: CARTaGENE (CaG) is a population-based prospective cohort study of individuals aged 40-69 years. We included only participants without prior ASCVD. The primary composite endpoint was time to the first ASCVD event (cardiovascular death, acute coronary syndrome, ischemic stroke/transient ischemic attack, or peripheral arterial vascular event)...
March 11, 2023: Canadian Journal of Cardiology